Nimodipine NDC 69452-209

NDC codes

FDA NDC Directory

Product NDC (as listed)69452-209Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69452-0209Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69452-209-13	69452020913	3 BLISTER PACK in 1 CARTON (69452-209-13) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACKMarketed from Nov 21, 2017
69452-209-20	69452020920	10 BLISTER PACK in 1 CARTON (69452-209-20) / 10 CAPSULE, LIQUID FILLED in 1 BLISTER PACKMarketed from Nov 21, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nimodipine
Generic name (nonproprietary): nimodipine
Active ingredients: Nimodipine — 30 mg/1
Dosage form: Capsule, Liquid filled
Route: Oral
Labeler: BIONPHARMA INC.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 076740
Marketing start: Nov 21, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Dihydropyridines (Chemical structure)
Identifiers: Product ID 69452-209_452704d5-dbeb-5833-e063-6394a90a1a9aSPL ID 452704d5-dbeb-5833-e063-6394a90a1a9aSPL set ID e65d5108-22a2-4d87-a78d-15606f3cc9e2RxCUI 198037UNII 57WA9QZ5WH
Pharmacologic class: Dihydropyridine Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469452020913 followed by a unit qualifier and the quantity

Package 69452-0209-13. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 4, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Nimodipine is indicated for the improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with subarachnoid hemorrhage from ruptured intracranial berry aneurysms regardless of their post-ictus neurological condition (i.e., Hunt and Hess Grades I-V).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)